PRM167 - MAPPING THE SF-36 TO EQ-5D-3L IN RANDOMIZED TRIAL- THE EMOCAR STUDY (MAY 2011 – APRIL 2016)
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2286
https://www.valueinhealthjournal.com/article/S1098-3015(18)35588-8/fulltext
Section Title :
Section Order :
1643
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35588-8&doi=10.1016/j.jval.2018.09.2286